Skip to main content

Advertisement

SpringerLink
Log in

Newborn Screening for Cystic Fibrosis

  • Published:
Clinical Reviews in Allergy & Immunology Aims and scope Submit manuscript

Abstract

Newborn screening (NBS) for cystic fibrosis (CF) has evolved considerably from its beginnings. We review the early history of NBS in the USA and the evolution of CF NBS from its conception in observational studies, to the development of mass-screening methodology in the 1970s, and to its early applications in the USA and other countries. We review the development of current CF NBS algorithms, particularly the development of those used in the Wisconsin randomized controlled trial, and discuss the comparative utility of different algorithms. We also discuss the identified nutritional and respiratory benefits of CF NBS, discuss treatment strategies for newborns identified with CF, and also discuss opportunities for slowing the progression of this disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Allen DB, Farrell PM (1996) Newborn screening: principles and practice. Adv Pediatr 43:231–270 (Review)

    PubMed  CAS  Google Scholar 

  2. CFTR Mutation Database. www.genet.sickkids.on.ca/cftr/app. Cited November 29, 2007

  3. Whitehead FJ, Couper RT, Moore L, Bourne AJ, Byard RW (1996) Dehydration deaths in infants and young children. Am J Forensic Med Pathol 17:73–78

    Article  PubMed  CAS  Google Scholar 

  4. Welsh MJ, Ramsey BW, Accurso FJ, Cutting GR (2001) Cystic fibrosis in the metabolic and molecular bases of inherited disease. McGraw-Hill, New York, pp 21–588

    Google Scholar 

  5. Phillips RJ, Crock CM, Dillon MJ, Clayton PT, Curran A, Harper JI (1993) Cystic fibrosis presenting as kwashiorkor with florid skin rash. Arch Dis Child 69:446–448

    PubMed  CAS  Google Scholar 

  6. Wilfond BS, Farrell PM, Laxova A, Mischler E (1994) Severe hemolytic anemia associated with vitamin E deficiency in infants with cystic fibrosis. Implications for neonatal screening. Clin Pediatr (Phila) 33:2–7

    CAS  Google Scholar 

  7. Crone J, Huber WD, Eichler I Granditsch G (2002) Acrodermatitis enteropathica-like eruption as the presenting sign of cystic fibrosis-case report and review of the literature. Eur J Pediatr 161:475–478

    Article  PubMed  Google Scholar 

  8. Merelle ME, Griffioen RW, Dankert-Roelse JE (2001) Cystic fibrosis presenting with intracerebral hemorrhage. Lancet 358:1960

    Article  PubMed  CAS  Google Scholar 

  9. Emerson J, Rosenfeld M, McNamara S, Ramsey B, Gibson RL (2002) Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis. Pediatr Pulmonol 34:91–100

    Article  PubMed  Google Scholar 

  10. Cystic Fibrosis Foundation National Patient Registry (2006). http://www.cff.org

  11. Guthrie R (1992) The origin of newborn screening. Screening 1:5–15

    Article  PubMed  CAS  Google Scholar 

  12. National Newborn Screening and Genetics Resource Center (NNSGRC) web site: GeNeS-R-US, (Genetic and Newborn Screening Resource Center of the United States) (genes-r-us.uthscsa.edu; (updated 10/17/07, accessed 11/29/2007)—Current Newborn Screening (NBS) Conditions-US by State (downloadable PDF file)

  13. Shwachman H, Redmond A, Khaw K-T (1970) Studies in cystic fibrosis: report of 130 patients diagnosed under 3 months of age over a 20-year period. Pediatrics 46:335–343

    PubMed  CAS  Google Scholar 

  14. Orenstein DM, Boat TF, Stern RC et al (1977) The effect of early diagnosis and treatment in cystic fibrosis: a seven-year study of 16 sibling pairs. Am J Dis Child 131:973–975

    PubMed  CAS  Google Scholar 

  15. Stephan U, Busch EW, Kollberg H et al (1975) Cystic fibrosis detection by means of a test strip. Pediatrics 55:35–38

    PubMed  CAS  Google Scholar 

  16. Bruns WT, Connell TR, Lacey JA et al (1977) Test strip meconium screening for cystic fibrosis. Am J Dis Child 131:71–73

    PubMed  CAS  Google Scholar 

  17. Phelan PD (1983) Screening for Cystic Fibrosis. Recent Adv Paediatr 7:103–120

    Google Scholar 

  18. Desai N, Nousia-Arvanitakis S (1977) False negative meconium test results in screening for cystic fibrosis. J Pediatr 91:447–448

    Article  PubMed  CAS  Google Scholar 

  19. Dankert-Roelse JE, Merelle ME (2005) Review of outcomes of neonatal screening for cystic fibrosis versus non-screening in Europe. J Pediatr 147:S15–S20

    Article  PubMed  Google Scholar 

  20. Crossley JR, Berryman CC, Elliott RB (1977) Cystic fibrosis screening in the newborn. Lancet 2(8048):1093–1095

    Article  PubMed  CAS  Google Scholar 

  21. Crossley JR, Elliott RB, Smith PA (1979) Dried-blood spot screening for cystic fibrosis in the newborn. Lancet 1:472–474

    Article  PubMed  CAS  Google Scholar 

  22. Waters DL, Wilcken B, Irwig L, VanAsperen P, Mellis C, Simpson JM, Brown J, Gaskin KJ (1999) Clinical outcomes of newborn screening for cystic fibrosis. Arch Dis Child Fetal Neonatal Ed 80:F1–F7

    PubMed  CAS  Google Scholar 

  23. Sontag MK, Hammond KB, Zielenski J, Wagener JS, Accurso FJ (2005) Two-tiered immunoreactive trypsinogen-based newborn screening for cystic fibrosis in Colorado: screening efficacy and diagnostic outcomes. J Pediatr 147:S83–S88

    Article  PubMed  CAS  Google Scholar 

  24. Gibson LE (1980) Screening of newborns for cystic fibrosis. Am J Dis Child 134:925–926

    PubMed  CAS  Google Scholar 

  25. Phelan PD (1982) Screening for cystic fibrosis (commentary on Dodge JA and Ryley HC:774–80). Am J Dis Child 57(10):779–780

    Google Scholar 

  26. Ad hoc committee task force on neonatal screening, Cystic Fibrosis Foundation (1983) Neonatal screening for cystic fibrosis: position paper. Pediatrics 72:741–745

    Google Scholar 

  27. Chatfield S, Owen G, Ryley HC, Williams J, Alfaham M, Goodchild MC, Weller P (1991) Neonatal screening for cystic fibrosis in Wales and the West Midlands: clinical assessment after five years of screening. Arch Dis Child 66:29–33

    Article  PubMed  CAS  Google Scholar 

  28. Newborn screening for cystic fibrosis (2004) MMWR October 15, 53: No. RR-13

  29. Fost N, Farrell PM (1989) A prospective randomized trial of early diagnosis and treatment of cystic fibrosis: a unique ethical dilemma. Clin Res 37:495–500

    PubMed  CAS  Google Scholar 

  30. Rock MJ, Mischler EH, Farrell PM, Bruns WT, Hassemer DJ, Laessig RH (1989) Immunoreactive trypsinogen screening for cystic fibrosis: characterization of infants with a false positive screening test. Pediatr Pulmonol 6:42–48

    Article  PubMed  CAS  Google Scholar 

  31. Laroche D, Travert G (1991) Abnormal frequency of DF508 mutation in neonatal transitory hypertrypsinaemia. Lancet 337:55

    Article  PubMed  CAS  Google Scholar 

  32. Gregg RG, Simantel A, Farrell PM et al (1997) Newborn screening for cystic fibrosis in Wisconsin: comparison of biochemical and molecular methods. Pediatrics 99:819–824

    Article  PubMed  CAS  Google Scholar 

  33. Farrell MH, Farrell PM (2003) Newborn screening for cystic fibrosis: ensuring more good than harm. J Pediatr 143:707–712

    Article  PubMed  Google Scholar 

  34. Watson MS, Cutting GR, Desnick RJ, Driscoll DA, Klinger K, Mennuti M et al (2004) Cystic fibrosis population carrier screening: 2004 revision of American College of Medical Genetics mutation panel. Genet Med 6:387–391

    Article  PubMed  Google Scholar 

  35. Massie RJ, Poplawski N, Wilcken B, Goldblatt J, Byrnes C, Robertson C (2001) Intron-8 polythymidine sequence in Australasian individuals with CF mutations R117H and R117C. Eur Respir J 17:1195–200

    Article  PubMed  CAS  Google Scholar 

  36. Scotet V, Audrezet M-P, Roussey M, Rault G, Dirou-Prigent A, Journel H et al (2006) Immunoreactive trypsin/DNA newborn screening for cystic fibrosis: should the R117H variant be included in CFTR mutation panels? Pediatrics 118:e1523–e1529

    Article  PubMed  Google Scholar 

  37. Chmiel JF, Drumm ML, Konstan MW, Ferkol TW, Kercsmar CM (1999) Pitfall in the use of genotype analysis as the sole diagnostic criterion for cystic fibrosis. Pediatrics 103:823–826

    Article  PubMed  CAS  Google Scholar 

  38. O’Sullivan BP, Zwerdling RG, Dorkin HL, Comeau AM, Parad R (2006) Early pulmonary manifestation of cystic fibrosis in children with the DeltaF508/R117H-7T genotype. Pediatrics 118:1260–1265

    Article  PubMed  Google Scholar 

  39. Bush A, Crowley S (2002) Cystic fibrosis: keeping it in the family. Pediatr Pulmonol 33:158–161

    Article  PubMed  Google Scholar 

  40. Lording A, McGaw M, Dalton A, Beal G, Everard M, Taylor CJ (2006) Pulmonary infection in mild variant cystic fibrosis: implications for care. J Cyst Fibros 5:101–104

    Article  PubMed  CAS  Google Scholar 

  41. Sims EJ, Clark A, McCormick J, Mehta G, Connett G, Mehta A (2007) Cystic fibrosis diagnosed after 2 months of age leads to worse outcomes and requires more therapy. Pediatrics 112(1):19–28

    Article  Google Scholar 

  42. Accurso FJ, Sontag MK, Wagener JS (2005) Complications associated with symptomatic diagnosis in infants with cystic fibrosis. J Pediatr 147:S37–S41

    Article  PubMed  Google Scholar 

  43. Farrell PM, Lai HJ, Li Z, Kosorok MR, Laxova A, Green CG, Collins J, Hoffman G, Laessig R, Rock MJ, Splaingard ML (2005) Evidence on improved outcomes with early diagnosis of cystic fibrosis through newborn screening: Enough is enough!. J Pediatr 147:S30–S36

    Article  PubMed  Google Scholar 

  44. Reardon MC, Hammond KB, Accurso FJ, Fisher CD, McCabe ERB, Cotton EK, Bowman CM (1984) Nutritional deficits exist before 2 months of age in some infants with cystic fibrosis identified by screening test. J Pediatr 105:271–274

    Article  PubMed  CAS  Google Scholar 

  45. Bronstein MN, Sokol RJ, Abman SH, Chatfield BA, Hammond KB, Hambidge KM, Stall CD, Accurso FJ (1992) Pancreatic insufficiency, growth, and nutrition in infants identified by newborn screening as having cystic fibrosis. J Pediatr 120:533–540

    Article  PubMed  CAS  Google Scholar 

  46. Giglio L, Candusso M, D'Orazio C, Mastella G, Faraguna D (1997) Failure to thrive-the earliest feature of cystic fibrosis in infants diagnosed by neonatal screening. Acta Paediatr 86:1162–1165

    Article  PubMed  CAS  Google Scholar 

  47. Koscik RL, Lai H-C, Laxova A, Zaremba KM, Kosorok MR, Douglas JA, Rock MJ, Splaingard ML, Farrell PM (2005) Preventing early, prolonged Vitamin E deficiency: an opportunity for better cognitive outcomes via early diagnosis through neonatal screening. J Pediatr 147:S51–S56

    Article  PubMed  Google Scholar 

  48. Siret D, Bretaudeau G, Branger B, Dabadic A, Dagorne M, David V et al (2003) Comparing the clinical evolution of cystic fibrosis screened neonatally to that of cystic fibrosis diagnosed from clinical symptoms: a 10-year retrospective study in a French region (Brittany). Pediatr Pulmonol 35:342–349

    Article  PubMed  CAS  Google Scholar 

  49. Konstan MW, Butler SM, Wohl MEB, Stoddard M, Matousek R, Wagener JS, Johnson CA, Morgan WJ, (ESCF) (2003) Growth and nutritional indices in early life predict pulmonary function in cystic fibrosis. J Pediatr 142:624–630

    Article  PubMed  Google Scholar 

  50. Feranchak AP, Sontag MK, Wagener JS, Hammond KB, Accurso FJ, Sokol RJ (1999) Prospective, long-term study of fat-soluble vitamin status in children with cystic fibrosis identified by newborn screen. J Pediatr 135(5):601–610

    Article  PubMed  CAS  Google Scholar 

  51. Lancellotti L, D’Orazio C, Mastella G, Mazzi G, Lippi U (1996) Deficiency of Vitamins E and A in cystic fibrosis is independent of pancreatic function and current enzyme and vitamin supplementation. Eur J Pediatr 155:281–285

    Article  PubMed  CAS  Google Scholar 

  52. Koscik R, Farrell P, Kosorok M, Zaremba K, Laxova A, Lai H-C, Douglas J, Rock M, Splaingard M (2004) Cognitive function of children with cystic fibrosis—deleterious effect of early malnutrition. Pediatrics 113:1549–1558

    Article  PubMed  Google Scholar 

  53. Laughlin JJ, Brady MS, Eigen H (1981) Changing feeding trends as a cause of electrolyte depletion in infants with cystic fibrosis. Pediatrics 68(2):203–207

    PubMed  CAS  Google Scholar 

  54. Haycock GB (1993) The influence of sodium on growth in infancy. Pediatr Nephrol 7:871–875

    Article  PubMed  CAS  Google Scholar 

  55. Ozcelik U Gocmen A, Kiper N, Coskun T, Yilmaz E, Ozguc M (1994) Sodium chloride deficiency in cystic fibrosis patients. Eur J Pediatr 153:829–831

    Article  Google Scholar 

  56. Coates A, Crofton PM, Marshall T (2005) Prospective audit of salt supplementation in CF infants. Pediatr Pulmonol Suppl 8:345–346

    Google Scholar 

  57. Mann M (2007) Precision of dosing sodium using per-packaged salt packets. Pediatr Pulmonol Suppl 30:383

    Google Scholar 

  58. Krebs NF, Westcott JE, Arnold TD, Kluger BM, Accurso FJ, Miller LV, Hambidge KM (2000) Abnormalities in zinc homeostasis in young infants with cystic fibrosis. Pediatr Res 48(2):256–261

    Article  PubMed  CAS  Google Scholar 

  59. Krebs NF, Sontag M, Accurso FJ, Hambidge KM (1998) Low plasma zinc concentrations in young infants with cystic fibrosis. J Pediatr 133:761–764

    Article  PubMed  CAS  Google Scholar 

  60. Strandvik B (2004) Fatty acid metabolism in cystic fibrosis(ed). NEJM 350(6):605–607

    Article  PubMed  CAS  Google Scholar 

  61. Van Egmond AWA, Kosorok MR, Koscik R, Laxova A, Farrell PM (l996) Effect of linoleic acid intake on growth of infants with cystic fibrosis. Am J Clin Nutr 63:746–752

    Google Scholar 

  62. Steinkamp G, Demmelmair H, Ruhl-Bagheri I, von der Hardt H, Koletzko B (2000) Energy supplements rich in linoleic acid improve body weight and essential fatty acid status of cystic fibrosis patients. JPGN 31:418–423

    PubMed  CAS  Google Scholar 

  63. Borowitz DS, Baker SS, Duffy L, Baker RD, Fitzpatrick L, Gyamfi J, Jarembek K (2004) Use of fecal elastase-1 to classify pancreatic status in patients with cystic fibrosis. J Pediatr 145:322–326

    Article  PubMed  CAS  Google Scholar 

  64. Beharry S, Ellis L, Corey M, Marcon M, Durie P (2002) How useful is fecal pancreatic elastase 1 as a marker of exocrine pancreatic disease? J Pediatr 141:84–90

    Article  PubMed  CAS  Google Scholar 

  65. Borowitz DS, Lin R, Baker SS (2007) Comparison of monoclonal and polyclonal ELISAs for fecal elastase in patients with cystic fibrosis and pancreatic insufficiency. JPGN 44:219–223

    PubMed  CAS  Google Scholar 

  66. Holliday KE, Allen JR, Waters DL, Gruca MA, Thompson SM, Gaskin KJ (1991) Growth of human milk-fed and formula-fed infants with cystic fibrosis. J Pediatr 118:77–79

    Article  PubMed  CAS  Google Scholar 

  67. Ellis L, Kalnins D, Corey M, Brennan J, Pencharz P, Durie P (1998) Do infants with cystic fibrosis need a protein hydrolysate formula? A prospective, randomized, comparative study. J Pediatr 132:270–276

    Article  PubMed  CAS  Google Scholar 

  68. Parker E, O’Sullivan B, Shea J, Regan M, Freedman S (2004) Survey of breast-feeding practices and outcomes in the cystic fibrosis population. Pediatr Pulmonol 37:362–367

    Article  PubMed  Google Scholar 

  69. Grosse SD, Rosenfeld M, Devine OJ et al (2006) Potential impact of newborn screening for cystic fibrosis on child survival: a systematic review and analysis. J Pediatr 149:362–366

    Article  PubMed  Google Scholar 

  70. Merelle ME, Schouten JP, Gerritsen J et al (2001) Influence of neonatal screening and centralized treatment on long-term clinical outcome and survival of CF patients. Eur Respir J 18:306–315

    Article  PubMed  CAS  Google Scholar 

  71. Farrell PM, Shen G, Splaingard M, Colby CE, Laxova A, Kosorok MR, Rock MJ, Mischler EH (1997) Acquisition of Pseudomonas aeruginosa in children with cystic fibrosis. Pediatrics 100(5). http://www.pediatrics.org/cgi/content/full/100/5/e2

  72. Rosenfeld M, Gibson RL, McNamara S, Emerson J, Burns JL, Castile R, Hiatt P, McCoy K, Wilson CB, Inglis A, Smith A, Martin TR, Ramsey BW (2001) Early pulmonary infection, inflammation, and clinical outcomes in infants with cystic fibrosis. Pediatr Pulmonol 32(5):356–366

    Article  PubMed  CAS  Google Scholar 

  73. Armstrong DS, Grimwood K, Carlin JB, Carzino R, Olinsky A Phelan PD (1996) Bronchoalveolar lavage or oropharyngeal cultures to identify lower respiratory pathogens in infants with cystic fibrosis.[see comment]. Pediatr Pulmonol 21(5):267–75

    Article  PubMed  CAS  Google Scholar 

  74. Treggiari MM, Rosenfeld M, Retsch-Bogart G, Gibson R, Ramsey B (2007) Approach to eradication of initial Pseudomonas aeruginosa infection in children with cystic fibrosis. Pediatr Pulmonol 42:751–756

    Article  PubMed  Google Scholar 

  75. Frederiksen B, Koch C, Hoiby N (1997) Antibiotic treatment of initial colonization with Pseudomonas aeruginosa postpones chronic infection and prevents deterioration of pulmonary function in cystic fibrosis. Pediatr Pulmonol 23:330–335

    Article  PubMed  CAS  Google Scholar 

  76. Southern KW, Munck A, Pollitt R, Travert G, Zanolla L, Dankert-Roelse J, Castellani C (2007) A survey of newborn screening for cystic fibrosis in Europe. J Cystic Fibrosis 6:57–65

    Article  CAS  Google Scholar 

  77. Sarles J (2005) Combining immunoreactive trypsinogen and pancreatitis-associated protein assays, a method of newborn screening for cystic fibrosis that avoids DNA analysis. J Pediatr 147:302–305

    Article  PubMed  CAS  Google Scholar 

  78. Comeau AM, Parad RB, Dorkin HL, Dovey M, Gerstle R, Haver K, Lapey A, O’Sullivan BP, Waltz DA, Zwerdling RG, Eaton RB (2004) Population-Based Newborn Screening for Genetic Disorders When Multiple Mutation DNA Testing Is Incorporated: A Cystic Fibrosis Newborn Screening Model Demonstrating Increased Sensitivity but More Carrier Detections. Pediatrics 113:1573–1581

    Article  PubMed  Google Scholar 

  79. Southern KW (2007) The challenge of screening newborn infants for cystic fibrosis. In: Hodson M, Geddes D, Bush A (eds) Cystic fibrosis, 3rd ed. Hodder Arnold, London

    Google Scholar 

  80. Comeau AM, Accurso FJ, White TB, Campbell PW, Hoffman G, Parad RB, Wilfond BS, Rosenfeld M, Sontag MK, Massie J, Farrell PM, O’Sullivan BP (2007) Guidelines for implementation of cystic fibrosis newborn screening programs: Cystic Fibrosis Foundation workshop report. Pediatrics 119:495–518

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pediatric Pulmonology, Department of Pediatrics, The Women and Children’s Hospital of Buffalo, The State University of New York at Buffalo, 219 Bryant Street, Buffalo, NY, 14222, USA

    Jack K. Sharp

  2. Clinical Sciences Center, K4/946, 600 Highland Avenue, Madison, WI, 53792, USA

    Michael J. Rock

Authors
  1. Jack K. Sharp
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael J. Rock
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jack K. Sharp.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sharp, J.K., Rock, M.J. Newborn Screening for Cystic Fibrosis. Clinic Rev Allerg Immunol 35, 107–115 (2008). https://doi.org/10.1007/s12016-008-8082-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12016-008-8082-1

Keywords

Search

Navigation